Metastasis-associated mutations in clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers Symposium. This abstract does not include a full text component ...
Prescriber treatment patterns for tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin (mTOR) inhibitors in patients with renal cell carcinoma.
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal and rare cancer session and a Society of Urologic Oncology (SUO) lecture ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果